May 4, 2020 / 12:31 PM / a month ago

BRIEF-Minerva Neurosciences Reports First Quarter 2020 Financial Results

May 4 (Reuters) - Minerva Neurosciences Inc:

* MINERVA NEUROSCIENCES REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND BUSINESS UPDATES

* Q1 LOSS PER SHARE $0.31

* Q1 EARNINGS PER SHARE ESTIMATE $-0.36 — REFINITIV IBES DATA

* EXPECT TO REPORT TOP LINE RESULTS IN Q2 FOR PIVOTAL PHASE 3 TRIAL WITH ROLUPERIDONE

* MINERVA NEUROSCIENCES - CASH, CASH EQUIVALENTS, RESTRICTED CASH AND MARKETABLE SECURITIES AS OF MARCH 31, 2020 WERE APPROXIMATELY $37.6 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below